171 related articles for article (PubMed ID: 8221626)
21. Rat p53 gene mutations in primary Zymbal gland tumors induced by 2-amino-3-methylimidazo[4,5-f]quinoline, a food mutagen.
Makino H; Ishizaka Y; Tsujimoto A; Nakamura T; Onda M; Sugimura T; Nagao M
Proc Natl Acad Sci U S A; 1992 Jun; 89(11):4850-4. PubMed ID: 1594584
[TBL] [Abstract][Full Text] [Related]
22. Identification of deletions and insertions in the p53 gene using multiplex PCR and high-resolution fragment analysis: application to breast and ovarian tumors.
Angelopoulou K; Diamandis EP
J Clin Lab Anal; 1998; 12(4):250-6. PubMed ID: 9671178
[TBL] [Abstract][Full Text] [Related]
23. Molecular analysis of T-cell receptor transcripts in a human T-cell leukemia bearing a t(1;14) and an inv(7); cell surface expression of a TCR-beta chain in the absence of alpha chain.
Bernard O; Groettrup M; Mugneret F; Berger R; Azogui O
Leukemia; 1993 Oct; 7(10):1645-53. PubMed ID: 8412327
[TBL] [Abstract][Full Text] [Related]
24. Transcriptionally active haptoglobin-related (Hpr) gene in hepatoma G2 and leukemia molt-4 cells.
Tabak S; Lev A; Valansi C; Aker O; Shalitin C
DNA Cell Biol; 1996 Nov; 15(11):1001-7. PubMed ID: 8945641
[TBL] [Abstract][Full Text] [Related]
25. Mutations of the p53 gene in human functional adrenal neoplasms.
Lin SR; Lee YJ; Tsai JH
J Clin Endocrinol Metab; 1994 Feb; 78(2):483-91. PubMed ID: 8106638
[TBL] [Abstract][Full Text] [Related]
26. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
Shieh YS; Nguyen C; Vocal MV; Chu HW
Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
[TBL] [Abstract][Full Text] [Related]
27. Genetic alteration of p53 in some patients with adult T-cell leukemia.
Nagai H; Kinoshita T; Imamura J; Murakami Y; Hayashi K; Mukai K; Ikeda S; Tobinai K; Saito H; Shimoyama M
Jpn J Cancer Res; 1991 Dec; 82(12):1421-7. PubMed ID: 1778765
[TBL] [Abstract][Full Text] [Related]
28. Genetic alterations at the splice junction of p53 gene in human hepatocellular carcinoma.
Hsu HC; Huang AM; Lai PL; Chien WM; Peng SY; Lin SW
Hepatology; 1994 Jan; 19(1):122-8. PubMed ID: 7903951
[TBL] [Abstract][Full Text] [Related]
29. An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide.
Chew SL; Lavender P; Clark AJ; Ross RJ
Endocrinology; 1995 May; 136(5):1939-44. PubMed ID: 7720641
[TBL] [Abstract][Full Text] [Related]
30. Immunologically distinct p53 molecules generated by alternative splicing.
Arai N; Nomura D; Yokota K; Wolf D; Brill E; Shohat O; Rotter V
Mol Cell Biol; 1986 Sep; 6(9):3232-9. PubMed ID: 3023970
[TBL] [Abstract][Full Text] [Related]
31. Novel polymerase chain reaction approach for full-coding p53 mutation detection in microdissected archival tumors.
Thompson-Hehir J; Davies MP; Green JA; Halliwell N; Joyce KA; Salisbury J; Sibson DR; Vergote I; Walker C
Diagn Mol Pathol; 2000 Jun; 9(2):110-9. PubMed ID: 10850547
[TBL] [Abstract][Full Text] [Related]
32. Genomic organization of the human beta-catenin gene (CTNNB1).
Nollet F; Berx G; Molemans F; van Roy F
Genomics; 1996 Mar; 32(3):413-24. PubMed ID: 8838805
[TBL] [Abstract][Full Text] [Related]
33. Detection of opioid receptor mRNA by RT-PCR reveals alternative splicing for the delta- and kappa-opioid receptors.
Gavériaux-Ruff C; Peluso J; Befort K; Simonin F; Zilliox C; Kieffer BL
Brain Res Mol Brain Res; 1997 Sep; 48(2):298-304. PubMed ID: 9332727
[TBL] [Abstract][Full Text] [Related]
34. Frequent mutations in the p53 tumor suppressor gene in human leukemia T-cell lines.
Cheng J; Haas M
Mol Cell Biol; 1990 Oct; 10(10):5502-9. PubMed ID: 2144611
[TBL] [Abstract][Full Text] [Related]
35. Multiple aberrant splicing of the p53 transcript without genomic mutations around exon-intron junctions in a case of chronic myelogenous leukaemia in blast crisis: a possible novel mechanism of p53 inactivation.
Nakai H; Kaneko H; Horiike S; Ariyama Y; Misawa S; Kashima K; Ishizaki K
Br J Haematol; 1994 Aug; 87(4):839-42. PubMed ID: 7527245
[TBL] [Abstract][Full Text] [Related]
36. Role of the p53 tumor suppressor gene in the pathogenesis and in the suppression of acute lymphoblastic T-cell leukemia.
Yeargin J; Cheng J; Haas M
Leukemia; 1992; 6 Suppl 3():85S-91S. PubMed ID: 1602834
[TBL] [Abstract][Full Text] [Related]
37. Identification of novel mRNA isoforms for human DNA polymerase beta.
Chyan YJ; Strauss PR; Wood TG; Wilson SH
DNA Cell Biol; 1996 Aug; 15(8):653-9. PubMed ID: 8769567
[TBL] [Abstract][Full Text] [Related]
38. Mutation analysis in two newly identified rat p53 pseudogenes.
Ciotta C; Dogliotti E; Bignami M
Mutagenesis; 1995 Mar; 10(2):123-8. PubMed ID: 7603328
[TBL] [Abstract][Full Text] [Related]
39. Familial hypercholesterolemia. Acceptor splice site (G-->C) mutation in intron 7 of the LDL-R gene: alternate RNA editing causes exon 8 skipping or a premature stop codon in exon 8. LDL-R(Honduras-1) [LDL-R1061(-1) G-->C].
Yu L; Heere-Ress E; Boucher B; Defesche JC; Kastelein J; Lavoie MA; Genest J
Atherosclerosis; 1999 Sep; 146(1):125-31. PubMed ID: 10487495
[TBL] [Abstract][Full Text] [Related]
40. Aberrant expression of the p53 tumor suppressor gene in adult T-cell leukemia and HTLV-I-infected cells.
Yamato K; Oka T; Hiroi M; Iwahara Y; Sugito S; Tsuchida N; Miyoshi I
Jpn J Cancer Res; 1993 Jan; 84(1):4-8. PubMed ID: 8449826
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
